Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 174
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login
Current Issue

January-February 2018 | Vol 7 | Issue 1

RSS Feed for Current Issue RSS Feed for Current Issue

 
Original Article
Clinicopathological attributes of T-lymphoblastic lymphoma seen in a tertiary care centre
Background and Aims: T-lymphoblastic lymphoma (T-LBL) is a type of non-Hodgkin lymphoma (NHL), the cell of origin being the precursor T cell. This study was undertaken to describe the distrib...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Retrospective comparative study between gemcitabine/cisplatin and gemcitabine/capecitabine in the treatment of metastatic carcinoma of gallbladder
Introduction: Metastatic carcinoma of gallbladder is a disease with a dismal prognosis. Chemotherapy is mainstay of treatment. Gemcitabine/cisplatin is used as first-line chemotherapy. In som...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Case Report
Diabetic mastopathy: An entity clinically mimicking malignancy; review of a series of three cases
Diabetic mastopathy is an unusual lesion affecting the breast of patients with longstanding diabetes mellitus (DM). This lesion presents as large hard masses, leading to clinical suspicion of malign...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
The expression level of vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, and insulin-like growth factor II mRNA binding protein 3 in renal cell carcinoma: Can these markers indicate poor prognosis in immunohistochemical examination?
Background: The malignant tumors of the kidney are the most aggressive among urologic cancers. To treat patients with renal cell carcinoma (RCC), it is important to understand the disease'...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Case Report
Primary Ewing's sarcoma/primitive neuroectodermal tumor of kidney: A rare case report
Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) is a member of small round cell “blue tumor” family, occurring primarily in kidney is quite rare. Hence, detail appraisal is...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Exlibris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet

The journal is indexed with, or included in, the following:
Emerging Sources Citation Index, Index Copernicus

 
  Clinical Cancer Investigation Journal

Clinical Cancer Investigation Journal, a publication of Middle-Eastern Association for Cancer Research (MEACR), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published.

More about the journal >>

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online